Clinical Trial Update: GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study of GLIDE regimen followed by autologous stem cell transplantation for extranodal NK/T-cell lymphoma (nasal type) is being investigated; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Etoposide (Etoposide)
• Gemcitabine (Gemcitabine)
• IFOSFAMIDE (IFOSFAMIDE)
• L-asparaginase (L-asparaginase)

Snippet

Sponsor: Sichuan University | Conditions: Lymphoma, Extranodal NK-T-Cell | Phase 2 | Status: UNKNOWN